.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Plenarsitzung

Immunotherapy: Primary T cells

Appointment

Date: 21/09/2023

Time: 10:30 – 12:00

Location / Stream:

MOA 04+05

Vorsitz

Language

Programme

10:30 – 11:00 30 Min. 0 Min.
Plenarvortrag
PL-2-1
Treatment with virus-specific T Cells
Prof. Dr. Tobias Feuchtinger (München/ DE)
11:00 – 11:30 30 Min. 0 Min.
Plenarvortrag
PL-2-2
Off the shelf multivirus-specific T cells to prevent or treat viral infections post-transplant
Dr. Ann M. Leen (Housten/TX/ US)
11:30 – 12:00 30 Min. 0 Min.
Plenarvortrag
PL-2-3
Virus-specific T-cells to treat progressive multifocal leukoencephalopathy (PML)
Prof. Dr. Thomas Skripuletz (Hannover/ DE)